English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/40761
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Autosomal Dominant Cone and Cone-Rod Dystrophy With Mutations in the Guanylate Cyclase Activator 1A Gene-Encoding Guanylate Cyclase Activating Protein-1

AuthorsDownes, Susan M.; Bhattacharya, Shom Shanker CSIC ORCID; Bird, Alan C.
Issue DateJan-2001
PublisherAmerican Medical Association
CitationArchives of Ophthalmology 119(1): 96-105 (2001)
Abstract[Objective]: To describe the phenotype in 3 families with dominantly inherited cone and cone-rod dystrophy with mutations in guanylate cyclase activator 1A (GUCA1A), the gene-encoding guanylate cyclase activator protein-1 (GCAP-1). [Methods]: Phenotypic characterization with psychophysical and electrophysiological evaluation and confocal laser scanning ophthalmoscopy was performed in 2 families with a Tyr99Cys mutation and 1 family with a Pro50Leu mutation. Haplotype analysis was performed in the families with Tyr99Cys mutation. [Results]: The families with a Y99C mutation were shown to be ancestrally related. Decreased visual acuity and loss of color vision occurred after the age of 20 years, followed by progressive atrophy of the central 5° to 10°. Electrophysiological testing revealed generalized loss of cone function, with preservation of rod function. Abnormal rod and cone sensitivities were confined to the central 5° to 10°. Confocal laser scanning ophthalmoscopy imaging showed abnormalities of autofluorescence in early disease. Subjects with a Pro50Leu mutation demonstrated marked variability in expressivity from minimal abnormalities of macular function to cone-rod dystrophy. [Conclusions]: The phenotype associated with the Y99C mutation in GUCA1A is distinctive, with little variation in expression. By contrast, that associated with the P50L mutation demonstrates variable expressivity. [Clinical Relevance]: Phenotype-genotype correlation in these 2 mutations demonstrates 2 different phenotypes.
Description10 páginas, 7 figuras, 1 tabla.-- et al.
Publisher version (URL)http://archopht.ama-assn.org/cgi/content/full/119/1/96
URIhttp://hdl.handle.net/10261/40761
ISSN0003-9950
Appears in Collections:(CABIMER) Artículos
Files in This Item:
There are no files associated with this item.
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.